Type2 Diabetes Clinical Trial
Official title:
Frequency Of Eye Problems In Type 2 Diabetes With Chronic Kidney Disease
This study evaluate the frequency and type of eye problem among Type 2 Diabetics with renal impairment and effect of renal impairment and haemodialysis on diabetic retinopathy
Chronic kidney disease is a descriptive term and is used for deteriorating kidney function of
any underlying cause. Chronic kidney disease implies longstanding (>3 months), potentially
progressive, impairment in renal function.(Kumar & Clark's ., 2016).
Diabetes mellitus is the most common cause of chronic kidney disease in developed countries.
In patients with diabetes, there is a steady advance from microalbuminuria to dipstick
positive proteinuria and a progression to renal failure. (Davidson's.,2014) .The most
commonly diagnosed diabetes-related complications is diabetic retinopathy. Its prevalence
increases with the duration of diabetes. Some 20%of people with type 1 diabetes will have
retinal changes after 10 years, rising to >95% after20 years; 20-30% of people with type 2
diabetes have retinopathy at diagnosis.(Kumar & Clark's ., 2016) .
Also from risk factors of diabetic retinopathy is nephropathy, and if severe, is associated
with worsening of Diabetic retinopathy. Conversely, treatment of renal disease (e.g. renal
transplantation) may be associated with improvement of retinopathy and a better response to
photocoagulation.(Kanaski ,2016) The high burden of ocular disease in Chronic kidney disease
can be explained, in part, by the sharing of risk factors common to both kidney and eye
diseases such as age, smoking, hypertension, diabetes, raised serum cholesterol and obesity.
Ocular diseases may also be directly linked to chronic kidney disease via common pathogenic
pathways, including, atherosclerosis, microangiopathy, inflammation and oxidative stress
(Wong et al., 2014).
In our study we seek to do the following for participants :
1. A detailed history including
1. Age, sex, smoking Habits
2. Duration of diabetes mellitus and treatment.
3. Chronic kidney disease stage by estimated glomerular filtration rate according to
MDRD formula
4. Duration of haemodialysis.
5. Associated co-morbidity as hypertension,
6. Therapeutic history eg; angiotensin converting enzyme, angiotensin II receptor
blocker, amiodarone, erythropoietin.
2. Complete Clinical examination including haemodynamics, complete cardiac, chest,
abdominal, lower limb examination, cranial nerve examination.
3. Complete eye examination including detailed fundus examination, classifying expected eye
problems as:
- Cataract. - Glaucoma
- Cranial nerve affection
- Retinopathy either proliferative, non proliferative or macular oedema.
4. The following investigations will be done:
- Serum creatinine & Blood Urea for estimation of glomerular filtration rate
- Glycated haemoglobin (HbA1c).
- lipogram.
- Complete blood count
- ECG
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03239366 -
A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population
|
Phase 2 | |
Completed |
NCT04597229 -
Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus
|
N/A | |
Completed |
NCT03623139 -
Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes
|
N/A | |
Active, not recruiting |
NCT04599920 -
Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life)
|
N/A | |
Active, not recruiting |
NCT03422471 -
Hypoglycemia and Autonomic Nervous System Function- B2
|
N/A | |
Completed |
NCT04382521 -
A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions
|
N/A | |
Recruiting |
NCT04564391 -
Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins
|
N/A | |
Recruiting |
NCT03458715 -
The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin
|
Phase 4 | |
Terminated |
NCT03278236 -
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?
|
N/A | |
Completed |
NCT02974504 -
Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
|
Phase 4 | |
Completed |
NCT05053828 -
Type 2 Diabetes With Antiplatelet Drugs
|
||
Not yet recruiting |
NCT03659383 -
The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine
|
Phase 4 | |
Completed |
NCT03542240 -
Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome
|
N/A | |
Completed |
NCT03657537 -
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
|
Phase 1 | |
Completed |
NCT03979768 -
Risk Assessment of Type 2 Diabetes in Pharmacies
|
N/A | |
Completed |
NCT03614039 -
Effect of Probiotic and Smectite Gel on NAFLD
|
N/A | |
Active, not recruiting |
NCT04994288 -
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03290768 -
Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)
|
N/A | |
Enrolling by invitation |
NCT04088851 -
"The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"
|
N/A | |
Completed |
NCT03643783 -
Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
|